NasdaqCM - Nasdaq Real Time Price USD

Precipio, Inc. (PRPO)

6.73

-0.97

(-12.60%)

At close: 4:00:00 PM EDT

8.59

+1.86

+(27.64%)

After hours: 5:59:44 PM EDT

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Name	Title	Pay	Exercised	Year Born
Mr. Ilan Danieli	Founder, President, CEO & Director	325.06k	--	1972
Mr. Ahmed Zaki Sabet	Chief Operating Officer	220.82k	--	1985
Dr. Ayman A. Mohamed M.D.	Chief Technology Officer	225.15k	--	1984
Mr. Matthew Gage	Chief Financial Officer	--	--	1967
Ms. Miri Chiko-Radomski	Chief Legal Counsel & People Officer	--	--	--

4 Science Park

3rd Floor

New Haven, CT 06511

United States

203 787 7888 https://www.precipiodx.com

Sector:: Healthcare
Industry:
Full Time Employees:: 54

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.

Precipio, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

May 12, 2025 at 8:00 PM UTC - May 16, 2025 at 8:00 PM UTC

Precipio, Inc. Earnings Date

April 10, 2025 at 12:00 AM UTC